Cellular Therapy Products: Types, Sources & Quality Standards (2026 Guide)

Comprehensive guide to cellular therapy products — mesenchymal stem cells, exosomes, SVF, and more. Learn about cell sources (Wharton's jelly, bone marrow, adipose), quality control standards, and why GMP manufacturing matters in regenerative medicine.

What Are Cellular Therapy Products?

Cellular therapy products (CTPs) are a regulated product category covering any therapeutic product containing living cells intended to alter, modify, or replace biological function. The category encompasses: haematopoietic stem cell transplants (bone marrow/cord blood — the oldest CTPs), CAR-T cell therapies for haematological cancers (Kymriah, Yescarta — FDA/EMA approved), MSC-based products (Alofisel® for Crohn's fistulae — EMA approved), and a growing pipeline of iPSC-derived CTPs in early trials. Not all CTPs are stem cell products — CAR-T cells are genetically engineered T lymphocytes, not stem cells.

Regulatory Pathways for Cellular Therapy Products

In the US, CTPs are regulated under 21 CFR Part 1271 (HCT/Ps) and, for more than minimally manipulated products, under the full BLA (Biologics License Application) pathway requiring Phase I–III clinical trials. In the EU, Advanced Therapy Medicinal Products (ATMPs) regulation governs CTPs — Alofisel® is the only MSC ATMP with EMA approval to date. In Turkey, the Ministry of Health's regenerative medicine framework permits GMP-certified MSC therapy under hospital exemptions, enabling clinical delivery of treatments not yet completed the full Western approval pathway.

What Patients Should Understand About "Approved" vs "Available"

The gap between scientific evidence and regulatory approval can be 10–20 years. MSC therapy has substantial peer-reviewed evidence across dozens of conditions but has not completed the full pharmaceutical approval pathway for most applications. This does not mean it is unsafe or ineffective — it means the commercial approval process is ongoing. Patients accessing MSC therapy at accredited international centres like StemCell Longevita receive treatment based on the published evidence base in a medically controlled setting, with full informed consent about the regulatory status in their home country.

Frequently Asked Questions

How does stem cell therapy reverse aging?

MSC therapy combats aging by replenishing the body's regenerative capacity, reducing chronic inflammation (inflammaging), improving cellular repair mechanisms, supporting telomere maintenance, and rejuvenating organ function at the cellular level.

What are the benefits of anti-aging stem cell therapy?

Benefits include improved skin elasticity and texture, increased energy levels, enhanced cognitive function, better sleep quality, improved immune function, reduced joint pain, and an overall sense of vitality and wellbeing.

How long do anti-aging stem cell therapy results last?

Most patients experience benefits lasting 12-18 months from a single treatment session. Many patients choose annual maintenance sessions to sustain and build upon their results over time.

What is the cost of anti-aging stem cell therapy in Istanbul?

Anti-aging stem cell therapy packages start from €6,950 at StemCell Longevita, including 30M+ MSCs, luxury hotel accommodation, VIP transfers, and comprehensive follow-up care. This is 50-85% less than comparable treatments in the US or Europe.

Related articles: Wharton's Jelly Stem Cells: Complete Guide to Umbilical Cord MSC Therapy | Mesenchymal Stem Cells (MSCs): What Every Patient Should Know | Types of Stem Cells Explained (2026 Update) | Exosome Therapy Benefits (2026 Research Update)

Related treatments: Anti-Aging Stem Cell Therapy | Autoimmune Disease Stem Cell Therapy | Osteoarthritis Stem Cell Therapy